Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2011, Article ID 609213, 10 pages
http://dx.doi.org/10.4061/2011/609213
Review Article

Renal Mitochondrial Cytopathies

1Division of Nephrology and Dialysis, Department of Nephrology and Urology, Bambino Gesù Children's Hospital and Research Institute, piazza Sant'Onofrio 4, 00165 Rome, Italy
2Nephrology and Dialysis Unit, Pediatric Department, Azienda Ospedaliera di Bologna, 40138 Bologna, Italy
3Clinical Genetics Unit, Department of Pediatrics, University of Padova, 35128 Padova, Italy
4Division of Metabolic Diseases, Department of Pediatric Medicine, Bambino Gesù Children's Hospital and Research Institute, 00165 Rome, Italy

Received 19 April 2011; Accepted 3 June 2011

Academic Editor: Patrick Niaudet

Copyright © 2011 Francesco Emma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Finsterer, “Mitochondriopathies,” European Journal of Neurology, vol. 11, no. 3, pp. 163–186, 2004. View at Publisher · View at Google Scholar
  2. S. Di Donato, “Multisystem manifestations of mitochondrial disorders,” Journal of Neurology, vol. 256, no. 5, pp. 693–710, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. S. DiMauro and E. A. Schon, “Mitochondrial respiratory-chain diseases,” New England Journal of Medicine, vol. 348, no. 26, pp. 2656–2668, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. E. Fosslien, “Mitochondrial medicine—molecular pathology of defective oxidative phosphorylation,” Annals of Clinical and Laboratory Science, vol. 31, no. 1, pp. 25–67, 2001. View at Google Scholar · View at Scopus
  5. C. M. Quinzii and M. Hirano, “Coenzyme Q and mitochondrial disease,” Developmental Disabilities Research Reviews, vol. 16, no. 2, pp. 183–188, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Casarin, J. C. Jimenez-Ortega, E. Trevisson et al., “Functional characterization of human COQ4, a gene required for Coenzyme Q10 biosynthesis,” Biochemical and Biophysical Research Communications, vol. 372, no. 1, pp. 35–39, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. R. Artuch, L. Salviati, S. Jackson, M. Hirano, and P. Navas, “Coenzyme Q10 deficiencies in neuromuscular diseases,” Advances in Experimental Medicine and Biology, vol. 652, pp. 117–128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Zeviani and V. Carelli, “Mitochondrial disorders,” Current Opinion in Neurology, vol. 20, no. 5, pp. 564–571, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. DiMauro and E. A. Schon, “Mitochondrial disorders in the nervous system,” Annual Review of Neuroscience, vol. 31, pp. 91–123, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. Sacconi, E. Trevisson, F. Pistollato et al., “hCOX18 and hCOX19: two human genes involved in cytochrome c oxidase assembly,” Biochemical and Biophysical Research Communications, vol. 337, no. 3, pp. 832–839, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. C. Wallace, G. Singh, M. T. Lott et al., “Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy,” Science, vol. 242, no. 4884, pp. 1427–1430, 1988. View at Google Scholar · View at Scopus
  12. I. J. Holt, A. E. Harding, and J. A. Morgan-Hughes, “Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies,” Nature, vol. 331, no. 6158, pp. 717–719, 1988. View at Google Scholar · View at Scopus
  13. C. T. Moraes, S. Shanske, H. J. Tritschler et al., “mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases,” American Journal of Human Genetics, vol. 48, no. 3, pp. 492–501, 1991. View at Google Scholar · View at Scopus
  14. R. McFarland, R. W. Taylor, and D. M. Turnbull, “Mitochondrial disease—its impact, etiology, and pathology,” Current Topics in Developmental Biology, vol. 77, pp. 113–155, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. E. Bertini, “Mitochondrial encephalomyopathies and related syndromes: brief review,” in Endocrine Involvement in Developmental Syndromes, M. Cappa, M. Maghnie, S. Loche, and G. F. Bottazzo, Eds., vol. 14, pp. 38–52, Karger, Basel, Switzerland, 2009. View at Google Scholar
  16. C. Bodemer, A. Rötig, P. Rustin et al., “Hair and skin disorders as signs of mitochondrial disease,” Pediatrics, vol. 103, no. 2, pp. 428–433, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Tiranti, P. D'Adamo, E. Briem et al., “Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein,” American Journal of Human Genetics, vol. 74, no. 2, pp. 239–252, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. R. Carrozzo, C. Dionisi-Vici, U. Steuerwald et al., “SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness,” Brain, vol. 130, no. 3, pp. 862–874, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. V. Valayannopoulos, C. Haudry, V. Serre et al., “New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria,” Mitochondrion, vol. 10, no. 4, pp. 335–341, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. Cízková, V. Stránecký, J. A. Mayr et al., “TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy,” Nature Genetics, vol. 40, no. 11, pp. 1288–1290, 2008. View at Publisher · View at Google Scholar · View at PubMed
  21. D. Rabier, C. Diry, A. Rotig et al., “Persistent hypocitrullinaemia as a marker for mtDNA NARP T 8993 G mutation?” Journal of Inherited Metabolic Disease, vol. 21, no. 3, pp. 216–219, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Ogasahara, A. G. Engel, D. Frens, and D. Mack, “Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 7, pp. 2379–2382, 1989. View at Google Scholar · View at Scopus
  23. R. Montero, J. A. Sánchez-Alcázar, P. Briones et al., “Analysis of Coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes,” Clinical Biochemistry, vol. 41, no. 9, pp. 697–700, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. M. López-Martín, L. Salviati, E. Trevisson et al., “Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis,” Human Molecular Genetics, vol. 16, no. 9, pp. 1091–1097, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. D. M. Kirby, D. R. Thorburn, D. M. Turnbull, and R. W. Taylor, “Biochemical assays of respiratory chain complex activity,” Methods in Cell Biology, vol. 80, pp. 93–119, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. F. Diomedi-Camassei, S. Di Giandomenico, F. M. Santorelli et al., “COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement,” Journal of the American Society of Nephrology, vol. 18, no. 10, pp. 2773–2780, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. Mita, B. Schmidt, E. A. Schon, S. DiMauro, and E. Bonilla, “Detection of “deleted” mitochondrial genomes in cytochromeoxidase-deficient muscle fibers of a patient with Kearns—Sayre syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 23, pp. 9509–9513, 1989. View at Publisher · View at Google Scholar · View at Scopus
  28. F. M. Santorelli, M. Sciacco, K. Tanji et al., “Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients,” Annals of Neurology, vol. 39, no. 6, pp. 789–795, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. M. J. Szabolcs, R. Seigle, S. Shanske, E. Bonilla, S. DiMauro, and V. D'Agati, “Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy,” Kidney International, vol. 45, no. 5, pp. 1388–1396, 1994. View at Google Scholar · View at Scopus
  30. F. Emma, C. Pizzini, A. Tessa et al., “"Bartter-like" phenotype in Kearns—Sayre syndrome,” Pediatric Nephrology, vol. 21, no. 3, pp. 355–360, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. P. Niaudet and A. Rotig, “The kidney in mitochondrial cytopathies,” Kidney International, vol. 51, no. 4, pp. 1000–1007, 1997. View at Google Scholar · View at Scopus
  32. J. M. Saudubray, D. Martin, P. de Lonlay et al., “Recognition and management of fatty acid oxidation defects: a series of 107 patients,” Journal of Inherited Metabolic Disease, vol. 22, no. 4, pp. 488–502, 1999. View at Google Scholar · View at Scopus
  33. Z. C. Falik-Borenstein, S. C. Jordan, J. M. Saudubray et al., “Brief report: renal tubular acidosis in carnitine palmitoyltransferase type 1 deficiency,” New England Journal of Medicine, vol. 327, no. 1, pp. 24–27, 1992. View at Google Scholar · View at Scopus
  34. R. Sharma, A. A. Perszyk, D. Marangi, C. Monteiro, and S. Raja, “Lethal neonatal carnitine palmitoyltransferase II deficiency: an unusual presentation of a rare disorder,” American Journal of Perinatology, vol. 20, no. 1, pp. 25–32, 2003. View at Google Scholar
  35. K. N. North, C. L. Hoppel, U. de Girolami, H. P. Kozakewich, and M. S. Korson, “Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys,” Journal of Pediatrics, vol. 127, no. 3, pp. 414–420, 1995. View at Google Scholar · View at Scopus
  36. J. Whitfield, D. Hurst, M. J. Bennett, W. G. Sherwood, R. Hogg, and W. Gonsoulin, “Fetal polycystic kidney disease associated with glutaric aciduria type II: an inborn error of energy metabolism,” American Journal of Perinatology, vol. 13, no. 3, pp. 131–134, 1996. View at Google Scholar · View at Scopus
  37. K. M. Au, S. C. Lau, Y. F. Mak et al., “Mitochondrial DNA deletion in a girl with Fanconi's syndrome,” Pediatric Nephrology, vol. 22, no. 1, pp. 136–140, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. E. Kuwertz-Bröking, H. G. Koch, T. Marquardt et al., “Renal Fanconi syndrome: first sign of partial respiratory chain complex IV deficiency,” Pediatric Nephrology, vol. 14, no. 6, pp. 495–498, 2000. View at Google Scholar · View at Scopus
  39. H. Mochizuiki, K. Joh, H. Kawame et al., “Mitochondrial encephalomyopathies preceded by de-Toni-Debré-Fanconi syndrome or focal segmental glomerulosclerosis,” Clinical Nephrology, vol. 46, no. 5, pp. 347–352, 1996. View at Google Scholar · View at Scopus
  40. R. D. Gilbert and M. Emms, “Pearson's syndrome presenting with Fanconi syndrome,” Ultrastructural Pathology, vol. 20, no. 5, pp. 473–475, 1996. View at Google Scholar · View at Scopus
  41. H. Matsutani, Y. Mizusawa, M. Shimoda et al., “Partial deficiency of cytochrome c oxidase with isolated proximal renal tubular acidosis and hypercalciuria,” Child Nephrology and Urology, vol. 12, no. 4, pp. 221–224, 1992. View at Google Scholar · View at Scopus
  42. L. Eviatar, S. Shanske, B. Gauthier et al., “Kearns-Sayre syndrome presenting as renal tubular acidosis,” Neurology, vol. 40, no. 11, pp. 1761–1763, 1990. View at Google Scholar · View at Scopus
  43. E. Martín-Hernández, M. T. García-Silva, J. Vara et al., “Renal pathology in children with mitochondrial diseases,” Pediatric Nephrology, vol. 20, no. 9, pp. 1299–1305, 2005. View at Publisher · View at Google Scholar · View at PubMed
  44. H. Antonicka, S. C. Leary, G. H. Guercin et al., “Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency,” Human Molecular Genetics, vol. 12, no. 20, pp. 2693–2702, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. I. Visapää, V. Fellman, J. Vesa et al., “GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L,” American Journal of Human Genetics, vol. 71, no. 4, pp. 863–876, 2002. View at Google Scholar · View at Scopus
  46. B. Acham-Roschitz, B. Plecko, F. Lindbichler et al., “A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy,” Molecular Genetics and Metabolism, vol. 98, no. 3, pp. 300–304, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. A. Saada, A. Shaag, S. Arnon et al., “Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation,” Journal of Medical Genetics, vol. 44, no. 12, pp. 784–786, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. R. Belostotsky, E. Ben-Shalom, C. Rinat et al., “Mutations in the mitochondrial Seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome,” American Journal of Human Genetics, vol. 88, no. 2, pp. 193–200, 2011. View at Publisher · View at Google Scholar · View at PubMed
  49. Y. Goto, N. Itami, N. Kajii, H. Tochimaru, M. Endo, and S. Horai, “Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns—Sayre syndrome,” Journal of Pediatrics, vol. 116, no. 6, pp. 904–910, 1990. View at Publisher · View at Google Scholar · View at Scopus
  50. K. H. Katsanos, M. Elisaf, E. Bairaktari, and E. V. Tsianos, “Severe hypomagnesemia and hypoparathyroidism in Kearns-Sayre syndrome,” American Journal of Nephrology, vol. 21, no. 2, pp. 150–153, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Endo and M. S. Sun, “Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells,” Journal of Inherited Metabolic Disease, vol. 25, no. 3, pp. 227–234, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. I. Nissim, O. Horyn, Y. Daikhin et al., “Ifosfamide-induced nephrotoxicity: mechanism and prevention,” Cancer Research, vol. 66, no. 15, pp. 7824–7831, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. F. Thévenod, “Nephrotoxicity and the proximal tubule. Insights from cadmium,” Nephron Physiology, vol. 93, no. 4, pp. 87–93, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. M. Lino, R. Binaut, L. H. Noël et al., “Tubulointerstitial nephritis and fanconi syndrome in primary biliary cirrhosis,” American Journal of Kidney Diseases, vol. 46, no. 3, pp. e41–e46, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. Y. Ueda, A. Ando, T. Nagata et al., “A boy with mitochondrial disease: asymptomatic proteinuria without neuromyopathy,” Pediatric Nephrology, vol. 19, no. 1, pp. 107–110, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. C. Y. Tzen, J. D. Tsai, T. Y. Wu et al., “Tubulointerstitial nephritis associated with a novel mitochondrial point mutation,” Kidney International, vol. 59, no. 3, pp. 846–854, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. A. Rötig, F. Goutières, P. Niaudet et al., “Deletion of mitochondrial DNA in a patient with chronic tubulointerstitial nephritis,” Journal of Pediatrics, vol. 126, no. 4, pp. 597–601, 1995. View at Google Scholar · View at Scopus
  58. R. Hameed, F. Raafat, P. Ramani, G. Gray, H. P. Roper, and D. V. Milford, “Mitochondrial cytopathy presenting with focal segmental glomerulosclerosis, hypoparathyroidism, sensorineural deafness, and progressive neurological disease,” Postgraduate Medical Journal, vol. 77, no. 910, pp. 523–526, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Gürgey, I. Özalp, A. Rötig et al., “A case of Pearson syndrome associated with multiple renal cysts,” Pediatric Nephrology, vol. 10, no. 5, pp. 637–638, 1996. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Müller Höcker, J. U. Walther, K. Bise, D. Pongratz, and G. Hübner, “Mitochondrial myopathy with loosely coupled oxidative phosphorylation in a case of Zellweger syndrome. A cytochemical-ultrastructural study,” Virchows Archive B: Cell Pathology Including Molecular Pathology, vol. 45, no. 2, pp. 125–138, 1984. View at Google Scholar · View at Scopus
  61. S. Güçer, B. Talim, E. Aşan et al., “Focal segmental glomerulosclerosis associated with mitochondrial cytopathy: report of two cases with special emphasis on podocytes,” Pediatric and Developmental Pathology, vol. 8, no. 6, pp. 710–717, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. S. Unal, H. S. Kalkanoğlu, C. Kocaefe et al., “Four-month-old infant with focal segmental glomerulosclerosis and mitochondrial DNA deletion,” Journal of Child Neurology, vol. 20, no. 1, pp. 83–84, 2005. View at Google Scholar · View at Scopus
  63. A. Goldenberg, L. H. Ngoc, M. C. Thouret et al., “Respiratory chain deficiency presenting as congenital nephrotic syndrome,” Pediatric Nephrology, vol. 20, no. 4, pp. 465–469, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. B. Guéry, G. Choukroun, L. H. Noël et al., “The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation,” Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 2099–2108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. J. J. Jansen, J. A. Maassen, F. J. van der Woude et al., “Mutation in mitochondrial tRNA(Leu(UUR)) gene associated with progressive kidney disease,” Journal of the American Society of Nephrology, vol. 8, no. 7, pp. 1118–1124, 1997. View at Google Scholar · View at Scopus
  66. L. Moulonguet Doleris, G. S. Hill, P. Chedin et al., “Focal segmental glomerulosclerosis associated with mitochondrial cytopathy,” Kidney International, vol. 58, no. 5, pp. 1851–1858, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. M. M. Löwik, F. A. Hol, E. J. Steenbergen, J. F. Wetzels, and L. P. van den Heuvel, “Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis,” Nephrology Dialysis Transplantation, vol. 20, no. 2, pp. 336–341, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. O. Hotta, C. N. Inoue, S. Miyabayashi, T. Furuta, A. Takeuchi, and Y. Taguma, “Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation,” Kidney International, vol. 59, no. 4, pp. 1236–1243, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. H. I. Cheong, J. H. Chae, J. S. Kim et al., “Hereditary glomerulopathy associated with a mitochondrial tRNA(Leu) gene mutation,” Pediatric Nephrology, vol. 13, no. 6, pp. 477–480, 1999. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Kurogouchi, T. Oguchi, E. Mawatari et al., “A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation,” American Journal of Nephrology, vol. 18, no. 6, pp. 551–556, 1998. View at Google Scholar · View at Scopus
  71. S. Nakamura, M. Yoshinari, Y. Doi et al., “Renal complications in patients with diabetes mellitus associated with an A to G mutation of mitochondrial DNA at the 3243 position of leucine tRNA,” Diabetes Research and Clinical Practice, vol. 44, no. 3, pp. 183–189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Hirano, K. Konishi, N. Arata et al., “Renal complications in a patient with A-to-G mutation of mitochondrial DNA at the 3243 position of leucine tRNA,” Internal Medicine, vol. 41, no. 2, pp. 113–118, 2002. View at Google Scholar · View at Scopus
  73. O. Musumeci, A. Naini, A. E. Slonim et al., “Familial cerebellar ataxia with muscle coenzyme Q10 deficiency,” Neurology, vol. 56, no. 7, pp. 849–855, 2001. View at Google Scholar · View at Scopus
  74. A. Rötig, E. L. Appelkvist, V. Geromel et al., “Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency,” Lancet, vol. 356, no. 9227, pp. 391–395, 2000. View at Google Scholar · View at Scopus
  75. L. Salviati, S. Sacconi, L. Murer et al., “Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition,” Neurology, vol. 65, no. 4, pp. 606–608, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. G. Montini, C. Malaventura, and L. Salviati, “Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency,” New England Journal of Medicine, vol. 358, no. 26, pp. 2849–2850, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. C. Quinzii, A. Naini, L. Salviati et al., “A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency,” American Journal of Human Genetics, vol. 78, no. 2, pp. 345–349, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. M. Forsgren, A. Attersand, S. Lake et al., “Isolation and functional expression of human COQ2, a gene encoding a polyprenyl transferase involved in the synthesis of CoQ,” Biochemical Journal, vol. 382, no. 2, pp. 519–526, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. J. Mollet, I. Giurgea, D. Schlemmer et al., “Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 765–772, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. L. C. López, M. Schuelke, C. M. Quinzii et al., “Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphote synthase subunit 2 (PDSS2) mutations,” American Journal of Human Genetics, vol. 79, no. 6, pp. 1125–1129, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. S. F. Heeringa, G. Chernin, M. Chaki et al., “COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness,” Journal of Clinical Investigation, vol. 121, no. 5, pp. 2013–2024, 2011. View at Publisher · View at Google Scholar · View at PubMed
  82. A. J. Duncan, M. Bitner-Glindzicz, B. Meunier et al., “A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease,” American Journal of Human Genetics, vol. 84, no. 5, pp. 558–566, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. C. Lagier-Tourenne, M. Tazir, L. C. López et al., “ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency,” American Journal of Human Genetics, vol. 82, no. 3, pp. 661–672, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. J. Mollet, A. Delahodde, V. Serre et al., “CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures,” American Journal of Human Genetics, vol. 82, no. 3, pp. 623–630, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. L. Barisoni, M. P. Madaio, M. Eraso, D. L. Gasser, and P. J. Nelson, “The kd/kd mouse is a model of collapsing glomerulopathy,” Journal of the American Society of Nephrology, vol. 16, no. 10, pp. 2847–2851, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. M. F. Lyon and E. V. Hulse, “An inherited kidney disease of mice resembling human nephronophthisis,” Journal of Medical Genetics, vol. 8, no. 1, pp. 41–48, 1971. View at Google Scholar · View at Scopus
  87. M. Peng, M. J. Falk, V. H. Haase et al., “Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease,” PLoS Genetics, vol. 4, no. 4, Article ID e1000061, 2008. View at Publisher · View at Google Scholar · View at PubMed
  88. M. Peng, L. Jarett, R. Meade et al., “Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice,” Kidney International, vol. 66, no. 1, pp. 20–28, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. R. Saiki, A. L. Lunceford, Y. Shi et al., “Coenzyme Q10 supplementation rescues renal disease in Pdss2 kd/kd mice with mutations in prenyl diphosphate synthase subunit 2,” American Journal of Physiology Renal Physiology, vol. 295, no. 5, pp. F1535–F1544, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. C. M. Quinzii, L. C. López, J. Von-Moltke et al., “Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency,” FASEB Journal, vol. 22, no. 6, pp. 1874–1885, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. C. M. Quinzii, L. C. López, R. W. Gilkerson et al., “Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency,” FASEB Journal, vol. 24, no. 10, pp. 3733–3743, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. L. C. López, C. M. Quinzii, E. Area et al., “Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects,” PLoS One, vol. 5, no. 7, Article ID e11897, 2010. View at Publisher · View at Google Scholar · View at PubMed
  93. A. Rodríguez-Hernández, M. D. Cordero, L. Salviati et al., “Coenzyme Q deficiency triggers mitochondria degradation by mitophagy,” Autophagy, vol. 5, no. 1, pp. 19–32, 2009. View at Google Scholar · View at Scopus
  94. G. Fernandes, E. J. Yunis, M. Miranda, J. Smith, and R. A. Good, “Nutritional inhibition of genetically determined renal disease and autoimmunity with prolongation of life in kdkd mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 6, pp. 2888–2892, 1978. View at Google Scholar · View at Scopus
  95. T. M. Hallman, M. Peng, R. Meade, W. W. Hancock, M. P. Madaio, and D. L. Gasser, “The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions,” Journal of Autoimmunity, vol. 26, no. 1, pp. 1–6, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. J. Hatanaka, Y. Kimura, Z. Lai-Fu, S. Onoue, and S. Yamada, “Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations,” International Journal of Pharmaceutics, vol. 363, no. 1-2, pp. 112–117, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus